Overlooked Changes To Patent Cooperation Treaty Practice - Law360

by Bradley Arant Boult Cummings LLP
Contact

Bradley Arant Boult Cummings LLP

The recent Actelion Pharmaceuticals Ltd. case brought to light a little-known quirk in how national stage patent applications affect the length of one’s patent term. That case involved a drug company losing five days of patent term due to an error in the national stage coversheet; unlike most errors during patent prosecution, this one could not be corrected. While five days of patent term is a small fraction of the entire term, sales of some blockbuster drugs are over $1 million per day. Actelion attempted to rely on the 2013 passage of the “Technical Corrections" section of the America Invents Act[1] to save its patent term, but to no avail.

More broadly, the Actelion case highlights the potential that an alternative filing procedure, often known as a “bypass” patent application, could have both resolved Actelion’s problem and potentially provided many other benefits. As a result of changes to the patent code from the America Invents Act, the Patent Law Treaties Implementation Act of 2012 (PLTIA) and the AIA's "Technical Corrections," the “bypass” application presents many potential advantages. Choosing between a national stage and a bypass is a key strategic decision during the prosecution of a U.S. patent.

The Patent Cooperation Treaty and the “Bypass” Application

The Patent Cooperation Treaty allows a patent applicant in any signatory country (such as the United States) to reserve its patent rights in all of the other 151 signatory countries by filing a single “international patent application.” Prior to the PCT, a U.S. inventor wishing to preserve patent rights in foreign countries was required to file a patent application in each foreign country within 12 months of filing a U.S. patent application. Under the PCT, once a single international application has been filed within 12 months, patent rights are preserved in all of the signatory countries for up to 30 months from the priority date. To pursue patent protection in individual national jurisdictions, the applicant must file local “national stage” applications in each country within the 30-month period. The PCT allows patent applicants to delay the significant expense of filing and prosecuting patent applications in national patent offices for an additional 18 months. This gives the applicant time to analyze the value of the invention in order to weigh the costs and benefits of filing patent applications.

International patent applications are often subject to distinct treatment by national patent laws because the treaty — not national law — defines their conditions and requirements. In the United States, one of the quirks resulting from the PCT is the ability to file two different types of applications relating to the international patent application.

One option is the standard national phase application. The national stage application is essentially the international application being treated as having entered into the United States, subject to any prosecution history of the international application (such as the international search and opinion).

The other option is the “bypass” application. A “bypass” application is filed as a “continuation” application under the “normal” (non-PCT) procedure under 35 U.S.C. § 111(a) that cites the international application for priority. This procedure treats the international stage application as simply another domestically filed U.S. application.

Bypass practice has generally been considered a secondary alternative to the PCT’s national stage route. Conventional wisdom has been that a national stage requires less paperwork, can cost less, and is less likely to provoke a restriction requirement than a bypass application. For these reasons, most attorneys have recommended proceeding with national stage applications, rather than bypass applications.

However, many subtle (and probably unintentional) changes in the law have erased most of the advantages the national stage once provided over a bypass. Consequently, the relative merits of the bypass have increased with little public attention.

The Current Benefits of Filing a Bypass Application

The National Stage RCE Trap

Under the AIA, the inventors’ oaths or declarations are no longer due upon filing, or within six months thereafter if not filed on the filing date. Instead, the declaration is not due in either a bypass or national stage until the payment of the issue fee.

However, the U.S. Patent and Trademark Office failed to change the requirements to file a request for continued examination in 37 C.F.R. § 114(e). Rule 114(e) prohibits an RCE from being filed in a national stage unless all requirements of 35 USC 371(c) have been fulfilled, including the requirement to file the oath/declaration. There is no such requirement to file an RCE in a bypass.

As a result, if an applicant needs an RCE in a national stage, but has not filed the declaration, the application may become abandoned as a result. Filing a bypass will avoid this complication, which may be especially desirable if filing of the oath/declaration will be delayed.

Track 1 Examination: Only for Bypass Applications

Obtaining “special status” permits prioritized examination. Prior to the AIA, special conditions had to be met to obtain special status (e.g., inventor over 65 years of age, positive international search work-product, etc.), so not all applications were eligible. Now, by paying a fee and limiting the number of claims, any applicant filing a domestic application under Section 111(a) can seek prioritized examination (Track 1). Because national stage applications are not filed under the authority of Section 111(a), Track 1 is not available for them. However, bypass applications can seek Track 1 examination.

A Bypass No Longer Requires a Copy of the Application

Originally, one of the greatest benefits of the PCT and the national stage application was that they did not require the applicant to provide another copy of the specification, claims, and drawings. Instead, the International Bureau of the World Intellectual Property Organization sends a copy to every national patent office for member nations. This reduced paperwork and provided one fewer opportunity for filing errors (such as lost pages).

However, the PLTIA has all but erased this advantage. The PLTIA allows an applicant for a U.S. patent to satisfy the requirement to file a specification and drawings by incorporation of an earlier patent application by reference. The earlier application can be an international application. Thus, a bypass can be filed without a copy of the specification and drawings simply by making such a reference in the application (there is a checkbox on the application data sheet for this). A copy will need to be filed eventually, once the USPTO sends a notice to file missing parts, but it is no longer necessary to be filed as of the filing date.

Disclaimer of Statements During International Stage

When trying to enforce a U.S. patent, any previous statements and amendments made on the record by the applicant can be used to narrow the scope of the claims during claim construction, to reduce or eliminate equivalents, and as fodder for allegations of inequitable conduct. Sometimes relevant statements are made during the processing of international applications, for example if Chapter II demand is made, if amendments are made under either of Rules 19 and 34, or if informal comments are made. A bypass, like any continuation application, can include a disclaimer of statements and amendments made during the prosecution of earlier applications (i.e., the international application), which is known as a Hakim disclaimer. A national stage cannot effectively include such disclaimers, because the national stage is considered the same application as the international application. If there is significant prosecution history during the international stage, it could be advantageous to file a bypass with a Hakim disclaimer.

A Bypass Can Contain New Matter

Because a bypass is really a continuation of the international application, it may be filed as any type continuation application, including as a “continuation-in-part.” Like any CIP, it may contain new matter compared to the parent, which in this case is the international application. Only claims that are fully supported by the international application in the manner required under 35 U.S.C. § 112 (enabled and with adequate written description) will be granted the effective filing date of the international application. In contrast, the national stage must be identical to the international application, and so cannot contain any new matter. Many commentators question the value of a CIP over a new application without a priority claim, but when a CIP of an international application is deemed necessary it is only available through bypass practice.

Fees Can Be Delayed for a Bypass

All patent applications require certain fee payments, and U.S. law has attempted to harmonize the fees due for a bypass and a national stage. However, a national stage that is filed without payment of the basic fee will not be accorded a filing date, which can result in abandonment. In contrast, a bypass will be accorded a filing date even if filed without any fees; the fees can be paid late. This reduces the impact of an unintentionally unpaid fee, and provides the opportunity to avoid the fees entirely if the applicant decides to abandon the application soon after filing.

When Would a National Stage Application be Preferred?

National Stage Can Salvage a Missed Filing Deadline

What happens if the 30-month deadline passes, but the applicant unintentionally neglected to file a U.S. application? In that case, it is too late to file a bypass. A bypass can only be filed while the international application is “pending,” and an international application is considered abandoned after the 30-month deadline. There is no mechanism under U.S. law for filing a bypass (or any other continuation of divisional application) after the parent application is abandoned.

However, the PTLIA created a mechanism for entering the national stage late, so long as the 30-month deadline was unintentionally missed. If the deadline has passed unintentionally, a national stage is the only option. This is the only recent change in the law that favors the filing of a national stage.

The Double-Edged Sword of Delayed Examination

While a bypass application permits prompt examination with few complications before the 30-month date, there is no option for delaying prosecution. To obtain examination before the 30-month date in a national stage application, the applicant must make an express request by checking the box (as Actelion belatedly learned, to its disadvantage). On the other hand, delay could be desirable to postpone costs associated with patent prosecution. In such cases, a national phase application may be preferable. While the bypass application eliminates the risk of accidentally delayed prosecution, there is no additional opportunity for delay once it is filed.

Fees May be Lower in a National Stage Application

In addition to the potential for delaying costs associated with active prosecution, the national stage application also offers an opportunity for lower fees. National stage fees are reduced if the USPTO was the international search authority, and they are actually eliminated if the USPTO as international search authority issues an opinion that all of the claims are novel, inventive, and industrially applicable.

Restriction Practice: Unity of Invention Versus Independent and Distinct

The requirements for an examiner to make a restriction requirement in a national stage are different than those in a bypass.

In a bypass, as in any other application filed under Section 111(a), under Section 121 restriction is proper if at least two claims are either independent or distinct from one another. To rebut a finding that two claims are independent or distinct, the applicant must establish that one of the claims is obvious over the other. This can be a very damaging admission. Furthermore, the legal definition of “distinct” in this context is notoriously vague. As a result, applicants frequently decline to rebut a restriction requirement.

In contrast, in a national stage restriction is proper if two claims lack “unity of invention.” Claims lack unity of invention if all of their common subject matter lacks novelty.[2] To rebut a finding of lack of unity the applicant must establish that the common subject matter is novel. This does not require an admission against interest. Furthermore, the unity of invention standard is much clearer than the independent/distinct standard and puts the burden on an examiner to identify art that renders the common subject matter of the two claims anticipated.

Conclusion

In the hoopla around the multiple statutory changes to the U.S. patent law this decade, some intricate details of the interface between U.S. law and the Patent Cooperation Treaty have escaped attention. Some developments, such as the RCE trap, were probably oversights. Others, such as limiting prioritized examination to bypass applications, seem to have been intentional, but it is not clear what policy goal they serve. Ironically, while one of the goals of patent reform was to harmonize U.S. law with international standards, these changes have exacerbated the asymmetries between bypasses and national stages. As a result, bypass applications may soon become more preferred over the national stage, as they offer many more advantages than were available before enactment of the AIA, "Technical Corrections," and the PLTIA. Applicants and attorneys should be aware of these changed incentives and choose a filing strategy accordingly.

[1] Pub. L. No. 112-274, 126 Stat. 2456 (2013).

[2] 37 C.F.R. § 1.475

Republished with permission. This article first appeared in Law360 on May 14, 2018.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bradley Arant Boult Cummings LLP | Attorney Advertising

Written by:

Bradley Arant Boult Cummings LLP
Contact
more
less

Bradley Arant Boult Cummings LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.